Revenue
2020
2021
Instil Bio, Inc. (TIL)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | $0 | $138,000 |
| Research & development | $24.7M | $11.8M | $39.6M | $141.1M | $107.3M | $19.4M |
| Operating expenses | $78.6M | $73.5M | $159.2M | $226.5M | $155.6M | $33.8M |
| Operating income | −$78.6M | −$73.5M | −$159.2M | −$226.5M | −$155.6M | −$33.6M |
| EBITDAderived | −$78.0M | −$69.9M | −$154.4M | −$220.5M | −$152.8M | −$33.4M |
| Net income | −$71.4M | −$74.1M | −$156.1M | −$223.2M | −$156.8M | −$37.7M |
| Basic EPSper diluted share | -$10.70 | -$11.39 | -$24.00 | -$34.46 | -$1.48 | -$2.36 |
| Diluted EPSper diluted share | -$10.70 | -$11.39 | -$24.00 | -$34.46 | -$1.48 | -$2.36 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Sep 10, 2025Form 4 | Laumas SandeepCFO and CBO | SellCommon Stock | 12.5K | $23.88 | $297.6K | 0 |
| Sep 10, 2025Form 4 | Laumas SandeepCFO and CBO | SellCommon Stock | 17.5K | $23.04 | $404.1K | 12.5K |